Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86399 | Target Info | |||
Target Name | Bromodomain-containing protein 2 (BRD2) | ||||
Synonyms | Really interesting new gene 3 protein; RING3; O27.1.1; KIAA9001 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BRD2 | ||||
Biochemical Class | Bromodomain | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (6~{R})-~{N}-(4-chlorophenyl)-1-methyl-8-(1-methylpyrazol-4-yl)-5,6-dihydro-4~{H}-[1,2,4]triazolo[4,3-a][1]benzazepin-6-amine | Ligand Info | |||
Canonical SMILES | CC1=NN=C2N1C3=C(C=C(C=C3)C4=CN(N=C4)C)C(CC2)NC5=CC=C(C=C5)Cl | ||||
InChI | 1S/C22H21ClN6/c1-14-26-27-22-10-8-20(25-18-6-4-17(23)5-7-18)19-11-15(3-9-21(19)29(14)22)16-12-24-28(2)13-16/h3-7,9,11-13,20,25H,8,10H2,1-2H3/t20-/m1/s1 | ||||
InChIKey | MDRXOFSNECSECW-HXUWFJFHSA-N | ||||
PubChem Compound ID | 139035062 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6K05 Crystal structure of BRD2(BD1)with ligand BY27 bound | ||||||
Method | X-ray diffraction | Resolution | 1.94 Å | Mutation | No | [1] |
PDB Sequence |
TNQLQYLHKV
85 VMKALWKHQF95 AWPFRQPVDA105 VKLGLPDYHK115 IIKQPMDMGT125 IKRRLENNYY 135 WAASECMQDF145 NTMFTNCYIY155 NKPTDDIVLM165 AQTLEKIFLQ175 KVASMPQE |
|||||
|
||||||
PDB ID: 6K04 Crystal structure of BRD2(BD2)with ligand BY27 bound | ||||||
Method | X-ray diffraction | Resolution | 1.25 Å | Mutation | No | [1] |
PDB Sequence |
SEQLKHCNGI
356 LKELLSKKHA366 AYAWPFYKPV376 DASALGLHDY386 HDIIKHPMDL396 STVKRKMENR 406 DYRDAQEFAA416 DVRLMFSNCY426 KYNPPDHDVV436 AMARKLQDVF446 EFRYAKMP |
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins. Eur J Med Chem. 2019 Nov 15;182:111633. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.